Top-ranked Barclays Analyst Raises Price Target for Coca Cola Europacific Partners

By Don Francis, Editor
May 15, 2024 7:10 AM UTC
Top-ranked Barclays Analyst Raises Price Target for Coca Cola Europacific Partners

Barclays's Lauren Lieberman raised their price target on Coca Cola Europacific Partners (NASDAQ: CCEP) by 7.7% from $78 to $84 on 2024/05/14. The analyst maintained their Strong Buy rating on the stock.

Lieberman hosted a meeting with Coca-Cola Europacific Partners management, and their takeaways catalyzed their price target hike. The analyst told investors the company presented "a very interesting" narrative and promising investment potential.

Barclays analyst Lauren Lieberman is ranked by WallStreetZen in the top 22% out of 4,585 Wall Street analysts, with an average return of 1.6% and a 56.8% win rate. They specialize in the Industrials and Basic Materials sectors, among others.

Coca-Cola Europacific Partners PLC, together with its subsidiaries, produces, distributes, and sells a range of non-alcoholic ready to drink beverages. The company offers flavors, mixers, and energy drinks; soft drinks, waters, enhanced water, and isotonic drinks; and ready-to-drink tea and coffee, juices, and other drinks. It provides its products under the Coca-Cola, Diet Coke, Coca-Cola Zero Sugar, Fanta, Sprite, Monster Energy, Coca-Cola Energy, Relentless, nalu, URGE, BURN, Kuli, REIGN, POWERADE, Appletiser, Schweppes, FINLEY, mezzo mix, Royal Bliss, Lift, Vio SCHORLE, Coca-Cola Signature Mixers, NORDIC MIST, smartwater, Chaudfontaine, AQUARIUS, VILAS del Turbon, BONAQUA, Apollinaris, Krystal, Honest, Costa Coffee, Fuzetea, CHAQWA, NESTEA, Capri-Sun, Oasis, Minute Maid, MER, and Tropico brands. In addition, the company engages in bottling and other operations. As of March 15, 2022, it served approximately 600 million consumers. The company was formerly known as Coca-Cola European Partners plc and changed its name to Coca-Cola Europacific Partners PLC in May 2021. Coca-Cola Europacific Partners PLC was founded in 1986 and is based in Uxbridge, the United Kingdom.

100% of top-rated analysts currently rate CCEP as a Strong Buy or Buy, no analysts see it as a Hold, and no analysts either recommend or strongly recommend selling the stock.

The consensus forecast among analysts is that CCEP's upcoming year will deliver earnings per share (EPS) of $3.91. If the analysts are right, CCEP's next yearly EPS will be down by 1.2% on a year-over-year basis.

Since CCEP's last quarterly report on 2023/12/31, the stock price is up 12.1%. Year-over-year, the stock is up 13.1%. During that period, CCEP is trailing the S&P 500, which is up 26.8%.

Is Coca Cola Europacific Partners a Buy, Hold or Sell?

WallStreetZen tracks the performance of nearly 4,000 Wall Street analysts, whom we rank by average returns, frequency, and win-rate (backtested over multiple years).

Create a free watchlist and be the first to know when top-rated Wall Street analysts revise their CCEP average stock price target.

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen and Don Francis do not hold any positions in the companies mentioned in this article. The information and statistics provided herein are presented for general informational purposes only and may not be accurate, complete, or up-to-date. It should not be interpreted as a recommendation to buy or sell any stocks and should not be solely relied upon for making investment decisions. It does not take into account your financial situation or risk profile. All investors should conduct their own investment due diligence before buying a stock. WallStreetZen expressly disclaims any liability for the accuracy, reliability, or completeness of the analysts' information, price targets, ratings, or opinions.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.